MarketLens

What is DecisionDx-Melanoma and Why Does it Matter for Investors

5 months ago

SHARE THIS ON:

Exclusive Content for Pro Members

Pro members only. Upgrade to access this article, premium analysis, and stock recommendations.

SHARE THIS ON:

What is Pfizer's Braftovi and Why Does it Matter for Investors

6 months ago

What is Agentic Testing and Why Does it Matter for Enterprises

2 months ago

What is PanTracer Pro and Why Does it Matter for Cancer Diagnostics

6 months ago

What is Seagate Technology Holdings and Why Does it Matter Now

3 months ago

SkylineDx's Merlin CP-GEP Granted FDA Breakthrough Device Designation, Building on Exclusive NCCN Recognition in Melanoma Care

SkylineDx's Merlin CP-GEP test received FDA Breakthrough Device Designation for melanoma care, building on its exclusive NCCN recognition. The designation could accelerate regulatory review and market...

Stock News•1 months ago

Immunocore: KIMMTRAK Is Becoming A Cash Engine For A Much Larger TCR Platform

Immunocore's KIMMTRAK global sales and five-year survival data fund a broad pipeline without dilutive equity. Upcoming catalysts include pivotal readouts for tebentafusp and brenetafusp in melanoma.

IMCR

Stock News•2 months ago

bioAffinity Technologies, Inc. (BIAF) Discusses Noninvasive Testing and Risk Stratification for Indeterminate Lung Nodules Transcript

bioAffinity Technologies discussed its noninvasive testing for indeterminate lung nodules. The company highlighted risk stratification capabilities, which could address a significant diagnostic gap.

BIAF

Stock News•3 months ago

Castle Biosciences, Inc. (CSTL) Q1 2026 Earnings Call Transcript

Castle Biosciences (CSTL) released its Q1 2026 earnings transcript, providing an update on the company's financial performance and operational progress. Investors are reviewing the report to assess cu...

CSTL